Compare · head to head
Caribou Biosciences vs Zenas Biopharma
Zenas Biopharma ranks higher overall — 360 rank 42 vs 39.
Caribou Biosciences leads on Quality (44 vs 38), Growth (65 vs 54) and Safety (49 vs 39). Zenas Biopharma leads on Sentiment (60 vs 46).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | Small |
| ISIN | US1420381089 | US98937L1052 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 39 | 42 |
| Value | 35 | NR |
| Quality | 44 | 38 |
| Growth | 65 | 54 |
| Safety | 49 | 39 |
| Sentiment | 46 | 60 |
| Quality details | ||
| Profitability | 30 | 26 |
| Cash Truth | 57 | NR |
Caribou Biosciences vs Adaptive BiotechnologiesCaribou Biosciences vs Legend BiotechAdd a third stock →
Full analyses: Caribou Biosciences · Zenas Biopharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100